Foghorn Therapeutics Inc. (FHTX)
3.43
0.06 (1.63%)
At close: Apr 02, 2025, 3:59 PM
3.31
-3.50%
After-hours: Apr 02, 2025, 05:01 PM EDT
Foghorn Therapeutics Revenue
Foghorn Therapeutics reported an annual revenue of $22.6M, reflecting a -33.83% growth. For the quarter ending December 31, 2024, Foghorn Therapeutics generated $2.86M in revenue.
Revenue (ttm)
$22.6M
Revenue Growth
-33.83%
Price / Sales Ratio
11.46
Revenue / Employee
$201.8K
Employees
112
Market Cap
190.75M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 22.6M | -33.83% |
Dec 31, 2023 | 34.16M | +77.63% |
Dec 31, 2022 | 19.23M | +1357.77% |
Dec 31, 2021 | 1.32M | +206.74% |
Dec 31, 2020 | 430K | n/a |